alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 7,751–7,775 of 27,380 studies, newest first · page 311 of 1096.

April 2023 25

  1. 2023-04-20

    Microbiota-gut-brain axis and related therapeutics in Alzheimer's disease: prospects for multitherapy and inflammation control

    ✓ Peer-reviewed Disease mechanisms Reviews in the neurosciences

    Key finding: As a result, researchers are exploring novel therapeutic modalities. +1 more finding

    Full summary, score breakdown and related studies → Original source

  2. 2023-04-20

    Plasma ATN(I) classification and precision pharmacology in Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Evaluating potential therapies for Alzheimer's disease (AD) depends on use of biomarkers for appropriate subject selection and monitoring disease progression. +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2023-04-20

    Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale

    ✓ Peer-reviewed Digital health tools Journal of the American Geriatrics Society

    Key finding: These results will inform the benefit of statins for increasing survival free of dementia and disability among older adults.

    Full summary, score breakdown and related studies → Original source

  4. 2023-04-20

    Relationships between hourly cognitive variability and risk of Alzheimer's disease revealed with mixed-effects location scale models

    ✓ Peer-reviewed Cognitive tests and assessment Neuropsychology

    Key finding: Preclinical AD risk, defined as possessing at least one APOE ε4 allele, is not only associated with mean-level performance differences, but also with increases in variability across repeated testing occasions particularly on a test of processing speed. +2 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2023-04-20

    Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Plasma and CSF p-tau 217 had equivalent diagnostic performance for biomarker-defined AD. +1 more finding

    Full summary, score breakdown and related studies → Original source

  6. 2023-04-20

    TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer

    ✓ Peer-reviewed TREM2 and immune genetics Nature immunology

    Key finding: Here, we sought to identify cues that alter NK cell activity in tumors. +3 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2023-04-19

    Combination of acetylcholinesterase inhibitors and NMDA receptor antagonists increases survival rate in soman-poisoned mice

    ✓ Peer-reviewed Treatments Toxicology mechanisms and methods

    Key finding: Commonly used drugs could ameliorate the intoxication and overall medical outcomes. +3 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2023-04-19

    An anti-amyloid therapy works for Alzheimer's disease: why has it taken so long and what is next?

    ✓ Peer-reviewed Treatments Brain : a journal of neurology

    Key finding: They argue that the results mark a turning point for the Alzheimer’s field, but that taking anti-amyloid therapies into clinical practice will be challenging.

    Full summary, score breakdown and related studies → Original source

  9. 2023-04-19

    Large-Scale Integration of Single-Cell RNA-Seq Data Reveals Astrocyte Diversity and Transcriptomic Modules across Six Central Nervous System Disorders

    ✓ Peer-reviewed Genetics Biomolecules

    Key finding: We found that astrocyte subtypes are regionally heterogeneous.

    Full summary, score breakdown and related studies → Original source

  10. 2023-04-19

    The structural and social determinants of Alzheimer's disease related dementias

    ✓ Peer-reviewed Disparities Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Under Bronfenbrenner's macrosystem framework, we highlight key quantitative and qualitative studies linking S/SDOH with AD/ADRD, identify scientific gaps in the literature, and propose guidance for future research.

    Full summary, score breakdown and related studies → Original source

  11. 2023-04-18

    Measures of cognitive reserve: An umbrella review

    ✓ Peer-reviewed Risk factors The Clinical neuropsychologist

    Key finding: Thirty-one reviews were identified, sixteen of which were systematic reviews, and fifteen were meta-analyses. +4 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2023-04-18

    Optical coherence tomography angiography in neuro-ophthalmology

    ✓ Peer-reviewed Brain scans and imaging Current opinion in ophthalmology

    Key finding: Optical coherence tomography angiography (OCTA) is a novel, noninvasive imaging technique, which provides depth resolved visualization of microvasculature of the retina and choroid. +2 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2023-04-18

    MicroRNA expression in extracellular vesicles as a novel blood-based biomarker for Alzheimer's disease

    ✓ Peer-reviewed Mild cognitive impairment Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Brain cell-derived small extracellular vesicles (sEVs) in blood offer unique cellular and molecular information related to the onset and progression of Alzheimer's disease (AD).

    Full summary, score breakdown and related studies → Original source

  14. 2023-04-17

    Brain iron content in cerebral amyloid angiopathy using quantitative susceptibility mapping

    ✓ Peer-reviewed Vascular contributions Frontiers in neuroscience

    Key finding: No differences were found between regions of interest in CAA compared to NC. +3 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2023-04-17

    Correlations between Cognitive Evaluation and Metabolic Syndrome

    ✓ Peer-reviewed Risk factors Metabolites

    Key finding: We found that MMSE and MoCA scores were associated with anthropometric parameters, and MoCA was associated with glycemic control parameters and leptin levels.

    Full summary, score breakdown and related studies → Original source

  16. 2023-04-17

    Lecanemab for Alzheimer's Disease: Effectiveness and Value — Final Evidence Report

    ⚠ Report — not peer-reviewed Costs and economics ICER (independent health technology assessment report)

    Key finding: Health-benefit price benchmark calculated at $8,900-$21,500 per year +3 more findings

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

    Full summary, score breakdown and related studies → Original source

  17. 2023-04-15

    Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics

    ✓ Peer-reviewed Treatments Drugs

    Key finding: The results of trials of anti-amyloid MABs support the amyloid hypothesis and amyloid as a target for AD drug development.

    Full summary, score breakdown and related studies → Original source

  18. 2023-04-15

    Potential Molecular Mechanisms of Alzheimer's Disease from Genetic Studies

    ✓ Peer-reviewed TREM2 and immune genetics Biology

    Key finding: We found that differences in molecular mechanisms in AD could be grouped into four key categories: sex-specific features, early-onset features, aging, and immune system pathways. +1 more finding

    Full summary, score breakdown and related studies → Original source

  19. 2023-04-14

    Sensory impairment and algorithmic classification of early cognitive impairment

    ✓ Peer-reviewed Risk factors Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: Cross-sectionally, participants with ≥3 SI had twice the prevalence of ECI (prevalence ratio = 2.10, p = 0.02). +4 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2023-04-14

    Enlarged perivascular spaces and plasma Aβ42/Aβ40 ratio in older adults without dementia

    ✓ Peer-reviewed Biomarkers Neurobiology of aging

    Key finding: A significant difference was observed in plasma Aβ42/Aβ40 ratio between low and high PVS burden, controlling for age (F[1, 53] = 5.59, p = 0.022, η2 = 0.10), with lower Aβ42/Aβ40 ratio in the high PVS burden group. +1 more finding

    Full summary, score breakdown and related studies → Original source

  21. 2023-04-14

    Chronic Pain Among Adults - United States, 2019-2021

    ⚠ Report — not peer-reviewed Risk factors MMWR. Morbidity and mortality weekly report

    Key finding: Population research objectives in the National Pain Strategy, which was released in 2016 by the Interagency Pain Research Coordinating Committee, call for more precise estimates of the prevalence of chronic pain and high-impact chronic pain (i.e., chronic pain that results in substantial restriction to daily activities) in the general population and within various population groups to guide efforts to reduce the impact of chronic pain (3).

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

    Full summary, score breakdown and related studies → Original source

  22. 2023-04-14

    Association between hearing aid use and all-cause and cause-specific dementia: an analysis of the UK Biobank cohort

    ⚠ Retracted — do not rely on it Long-term cohort studies The Lancet. Public health

    Key finding: Dementia and hearing loss are both highly prevalent conditions among older adults. +3 more findings

    Scored 42 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

    Full summary, score breakdown and related studies → Original source

  23. 2023-04-13

    Blood β-synuclein is related to amyloid PET positivity in memory clinic patients

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Plasma β-synuclein demonstrated discriminative properties for Aβ PET positive and negative subjects. +2 more findings

    Full summary, score breakdown and related studies → Original source

  24. 2023-04-12

    A glycan epitope correlates with tau in serum and predicts progression to Alzheimer's disease in combination with APOE4 allele status

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Bisecting N-acetylglucosamine correlated with tau levels (p < 0.0001). +3 more findings

    Full summary, score breakdown and related studies → Original source

  25. 2023-04-12

    Effectiveness of computer-based interventions for community-dwelling people with cognitive decline: a systematic review with meta-analyses

    ✓ Peer-reviewed Digital health tools BMC geriatrics

    Key finding: The results demonstrated that CCIs have beneficial effects on domain-specific cognition in people with MCI but no significant effects on people with dementia. +4 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →